393 related articles for article (PubMed ID: 33743480)
1. SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC).
Gauci ML; Coutzac C; Houot R; Marabelle A; Lebbé C;
Eur J Cancer; 2021 May; 148():121-123. PubMed ID: 33743480
[No Abstract] [Full Text] [Related]
2. What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective.
Spadaccini M; Canziani L; Aghemo A; Lleo A; Maselli R; Anderloni A; Carrara S; Fugazza A; Pellegatta G; Galtieri PA; Hassan C; Greenwald D; Pochapin M; Wallace M; Sharma P; Roesch T; Bhandari P; Emura F; Raju GS; Repici A
United European Gastroenterol J; 2021 Sep; 9(7):787-796. PubMed ID: 34102015
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
Luxi N; Giovanazzi A; Capuano A; Crisafulli S; Cutroneo PM; Fantini MP; Ferrajolo C; Moretti U; Poluzzi E; Raschi E; Ravaldi C; Reno C; Tuccori M; Vannacci A; Zanoni G; Trifirò G;
Drug Saf; 2021 Dec; 44(12):1247-1269. PubMed ID: 34739716
[TBL] [Abstract][Full Text] [Related]
4. Does COVID-19 Vaccination Warrant the Classical Principle "
Doulberis M; Papaefthymiou A; Kotronis G; Gialamprinou D; Soteriades ES; Kyriakopoulos A; Chatzimichael E; Kafafyllidou K; Liatsos C; Chatzistefanou I; Anagnostis P; Semenin V; Ntona S; Gkolia I; Papazoglou DD; Tsinonis N; Papamichos S; Kirbas H; Zikos P; Niafas D; Kountouras J
Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803295
[TBL] [Abstract][Full Text] [Related]
5. The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.
Malek AE; Cornejo PP; Daoud N; Alam M
Immunotherapy; 2022 Feb; 14(2):91-94. PubMed ID: 34747190
[No Abstract] [Full Text] [Related]
6. ChAdOx1 nCoV-19 effectiveness during an unprecedented surge in SARS COV-2 infections.
Satwik R; Satwik A; Katoch S; Saluja S
Eur J Intern Med; 2021 Nov; 93():112-113. PubMed ID: 34419309
[No Abstract] [Full Text] [Related]
7. Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk.
Golan Y; Prahl M; Cassidy A; Lin CY; Ahituv N; Flaherman VJ; Gaw SL
JAMA Pediatr; 2021 Oct; 175(10):1069-1071. PubMed ID: 34228115
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors.
Switzer B; Haanen J; Lorigan PC; Puzanov I; Turajlic S
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34272309
[TBL] [Abstract][Full Text] [Related]
9. Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
Carlson RD; Flickinger JC; Snook AE
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32283684
[TBL] [Abstract][Full Text] [Related]
10. Blood neutrophil subset predicts the success of immune checkpoint inhibitors in cancer.
Bordon Y
Nat Rev Immunol; 2024 Feb; 24(2):89. PubMed ID: 38225275
[No Abstract] [Full Text] [Related]
11. Re: 'Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals'.
Daungsupawong H; Wiwanitkit V
Eur J Clin Invest; 2024 May; 54(5):e14170. PubMed ID: 38240119
[No Abstract] [Full Text] [Related]
12. Does the World Still Need New Covid-19 Vaccines?
Nohynek H; Wilder-Smith A
N Engl J Med; 2022 Jun; 386(22):2140-2142. PubMed ID: 35507476
[No Abstract] [Full Text] [Related]
13. PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy.
Sacchelli L; Filippi F; Balato A; Balestri R; Bellinato F; Bernardini N; Bianchi L; Burlando M; Campanati A; Chessa MA; Corazza M; Di Cesare A; Di Lernia V; Diotallevi F; Esposito M; Fargnoli MC; Gisondi P; Giunta A; Hansel K; Magnano M; Megna M; Odorici G; Prignano F; Potenza C; Rech G; Rovesti M; Ruggiero A; Satolli F; Stingeni L; Gibertoni D; Bardazzi F
J Eur Acad Dermatol Venereol; 2024 Mar; 38(3):e215-e218. PubMed ID: 38059550
[No Abstract] [Full Text] [Related]
14. Oncology: What You May Have Missed in 2023.
Coschi CH; Dodbiba L; Guerry D
Ann Intern Med; 2024 May; 177(5_Supplement):S57-S70. PubMed ID: 38621244
[TBL] [Abstract][Full Text] [Related]
15. Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies.
Kleebayoon A; Wiwanitkit V
Clin Lung Cancer; 2023 Jul; 24(5):e161. PubMed ID: 37088613
[No Abstract] [Full Text] [Related]
16. Immune-Checkpoint Inhibitors in the Hepatitis C-Infected Patient: To Use or Not to Use?
Barnhill MS; Vargas HE
Am J Gastroenterol; 2023 Sep; 118(9):1554-1555. PubMed ID: 37417784
[No Abstract] [Full Text] [Related]
17. Improving COVID-19 vaccine response in individuals receiving methotrexate.
Bechman K; Galloway J
Lancet Rheumatol; 2024 Feb; 6(2):e67-e68. PubMed ID: 38267103
[No Abstract] [Full Text] [Related]
18. Transitioning to a New Normal after COVID-19: Preparing to Get Back on Track for Cancer Imaging.
Luker GD; Boettcher AN
Radiol Imaging Cancer; 2020 May; 2(3):e204011. PubMed ID: 33778714
[No Abstract] [Full Text] [Related]
19. Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors.
Waissengrin B; Agbarya A; Safadi E; Padova H; Wolf I
Lancet Oncol; 2021 May; 22(5):581-583. PubMed ID: 33812495
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 vaccines for cancer patients: a call to action.
Corti C; Crimini E; Tarantino P; Pravettoni G; Eggermont AMM; Delaloge S; Curigliano G
Eur J Cancer; 2021 May; 148():316-327. PubMed ID: 33770576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
